As in SF188, it also led to the downregulation of previously published target genes of MLL1 and MLL2 (Fig. 5D, E), as well as genes that are part of the network of transcription factors that are aberrantly expressed in glioblastoma in GPC16 cells (Fig. 5F). This evidence concerns the gene KMT2A and glioblastoma.